The author of a new guidebook on GLP-1s and other experts share their tips for how clinicians can optimize patient success ...

Research has found that GLP-1 receptors, found in medications like Wegovy and Monjaro, may offer health benefits beyond the ...

Now that Novo Nordisk is the world’s weight-loss juggernaut, will it have to betray its first patients—type 1 diabetics?

CEPI grant aims to build on evidence of Micron Biomedical’s needle-free delivery of vaccines to bring CastleVax’s novel rapid-response platform to the clinic OSLO, Norway and ATLANTA, Jan. 08, 2025 ...

WEDNESDAY, Jan. 8, 2025 (HealthDay News) -- Three GLP-1 drugs are best at helping obese and overweight people drop weight, including one that hasn’t yet been approved for that purpose. However ...

A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic. Experts ...

Choi_ Nikolai - stock.adobe.com They’re not biting. As Ozempic and other GLP-1 drugs change the way America eats, food manufacturers are trying to whip themselves up a forkful of the action ...

In December 2022, she was prescribed Ozempic. Her mom was hesitant, but Weaver told her, “This is something I want to do.” She also made lifestyle changes, adding a weight-lifting routine ...

Allowing yourself grace, patience and respect." Though Aguilera's appearance has sparked debate online about whether she has dabbled with Ozempic, the "Beautiful" singer has not directly addressed ...

Kennedy stated that there's a huge push to sell this to the American people, in response to Fox News' Greg Gutfeld's October question about his opinion of the semaglutide drug Ozempic. This medication ...

Known by trade names such as Ozempic, Wegovy, and others, these GLP-1 agonists have dramatically reduced obesity for diabetes patients, and their use has quickly broadened into popular culture.